Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers attend Royal Institution Family Fun Day

Engagement Opportunities Research

How can genome editing improve human health? That's the theme researchers from the MRC Weatherall Institute of Molecular Medicine (MRC WIMM) took to the latest Royal Institution Family Fun Day in London.

MRC WIMM researchers were enthusiastic participants of the Family Fun Day at the Royal Institution in London this past Saturday, part of a series of events around this year's Ri Christmas Lectures. The action packed day included talks, demonstrations and experiments exploring the science behind what makes each of us unique.

The MRC WIMM's contribution focused on how genome editing is helping biomedical research, and was part of the UKRI sponsored rooms, representing the Medical Research Council. Our colourful stand explored the science of genome editing, from the basics of the technique to its applications in medical research. The stand was originally developed for the MRC Festival of Medical Research 2018, but has since been taken to the Oxford Science and Ideas Festival and several local schools.

Read more (MRC WIMM website)

Similar stories

General anaesthesia should be available for dying patients - medical and ethical experts

General Research

General anaesthesia should be more widely available for patients at the end of their lives, according to Oxford experts in ethics and anaesthesia, according to a paper published by Anaesthesia (a journal of the Association of Anaesthetists).

Risk of rare blood clotting higher for COVID-19 than for vaccines

Coronavirus COVID-19 Research

COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Clinical Trials Coronavirus COVID-19 Research

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

Cognitive behavioural therapy: we discovered a data gap on its effectiveness for different ethnic groups

General Research

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.